Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis
This study has been completed.
Study NCT00437255   Information provided by Galderma Laboratories, L.P.
First Received: February 16, 2007   Last Updated: April 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Plaque Psoriasis
Additional conditions recognized in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
Clobetasol Propionate, 0.05%
Additional drug interventions recognized in this trial
Betamethasone
Betamethasone sodium phosphate
Betamethasone-17,21-dipropionate
Calcipotriene
Calcitriol
Clobetasol
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Bone Density Conservation Agents
Calcium Channel Agonists
Cardiovascular Agents
Dermatologic Agents
Glucocorticoids
Growth Substances
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Membrane Transport Modulators
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Vasoconstrictor Agents
Vitamins
Sponsors listed in this trial
Galderma Laboratories, L.P.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services